Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adicet Bio Inc. (ACET)

13.15   -1.41 (-9.68%) 01-19 08:44
Open: 14.41 Pre. Close: 14.56
High: 14.4699 Low: 13.09
Volume: 329,452 Market Cap: 515M
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.483 - 14.585 14.585 - 14.664
Low: 12.913 - 13.014 13.014 - 13.091
Close: 13.021 - 13.174 13.174 - 13.293

Technical analysis

as of: 2022-01-19 8:18:56 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 19.11     One year: 21.60
Support: Support1: 12.92    Support2: 10.75
Resistance: Resistance1: 16.36    Resistance2: 18.49
Pivot: 15.60
Moving Average: MA(5): 14.00     MA(20): 15.65
MA(100): 10.56     MA(250): 11.38
MACD: MACD(12,26): 0.08     Signal(9): 0.65
Stochastic oscillator: %K(14,3): 7.56     %D(3): 8.51
RSI: RSI(14): 41.32
52-week: High: 18.49  Low: 6.25  Change(%): -10.5
Average Vol(K): 3-Month: 124147  10-Days: 31701

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ACET has closed above bottom band by 8.3%. Bollinger Bands are 103% wider than normal. The large width of the bands suggest high volatility as compared to ACET's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Tue, 04 Jan 2022
Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Rises By 258.3% - MarketBeat

Mon, 03 Jan 2022
3 Biotech Stocks That Could Double in 2022 - Nasdaq

Sat, 01 Jan 2022
What Type Of Shareholders Make Up Adicet Bio, Inc.'s (NASDAQ:ACET) Share Registry? - Nasdaq

Wed, 08 Dec 2021
Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewswire

Mon, 06 Dec 2021
Why Adicet Bio Stock Is Skyrocketing Today - Motley Fool

Mon, 08 Nov 2021
Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference - Yahoo Finance

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Basic Materials
Industry:  Biotechnology
Shares Out. (M) 39
Shares Float (M) 13
% Held by Insiders 11.42
% Held by Institutions 60.94
Shares Short (K) 910
Shares Short P. Month (K) 301

Stock Financials

EPS -2.010
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 6.800
Profit Margin
Operating Margin -474.05
Return on Assets (ttm) -14.1
Return on Equity (ttm) -33.0
Qtrly Rev. Growth 13.2
Gross Profit (p.s.) 0.457
Sales Per Share 0.247
EBITDA (p.s.) -1.133
Qtrly Earnings Growth
Operating Cash Flow (M) -51
Levered Free Cash Flow (M) -36

Stock Valuations

PE Ratio -6.54
PEG Ratio
Price to Book value 1.93
Price to Sales 53.22
Price to Cash Flow -10.10

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2020-09-15
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.